Depósito Digital de Documentos de la UAB Encontrados 5 registros  La búsqueda tardó 0.00 segundos. 
1.
15 p, 1.9 MB In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer / Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Garcia, Elena (Luxembourg Institute of Health) ; Dittmar, Gunnar (Luxembourg Institute of Health) ; Nazarov, Petr V. (Luxembourg Institute of Health) ; Bebia, Vicente (Hospital Universitari Vall d'Hebron) ; Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) mortality is directly associated with the presence of poor prognostic factors. Molecular prognostic factors have been identified, but none are used in clinical practice due to lack of validation studies. [...]
2021 - 10.3390/cancers13205052
Cancers, Vol. 13 (october 2021)  
2.
17 p, 2.5 MB Cervical Fluids Are a Source of Protein Biomarkers for Early, Non-Invasive Endometrial Cancer Diagnosis / Martinez-Garcia, Elena (Luxembourg Institute of Health) ; Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lesur, Antoine (Luxembourg Institute of Health) ; Dittmar, Gunnar (University of Luxembourge) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron) ; Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Abnormal uterine bleeding (AUB) is the main symptom of endometrial cancer (EC), but it is highly nonspecific. This represents a huge burden for women's health, since all women presenting with bleeding will undergo sequential invasive tests, avoidable in 90-95% of those women who do not have EC. [...]
2023 - 10.3390/cancers15030911
Cancers, Vol. 15 (january 2023)  
3.
20 p, 2.0 MB Prognostic Biomarkers in Endometrial Cancer : A Systematic Review and Meta-Analysis / Coll de la Rubia, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Garcia, Elena (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ; Dittmar, Gunnar (Quantitative Biology Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg; (E.M.-G.); (G.D.)) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth most common cancer in women worldwide and its mortality is directly associated with the presence of poor prognostic factors driving tumor recurrence. Stratification systems are based on few molecular, and mostly clinical and pathological parameters, but these systems remain inaccurate. [...]
2020 - 10.3390/jcm9061900
Journal of clinical medicine, Vol. 9 (june 2020)  
4.
17 p, 4.8 MB ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer / Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moiola, Cristian Pablo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quiles, Maria Teresa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Arbós i Via, Maria Antònia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Stirbat, Tomita Vasilica (Institut Curie) ; Brochard-Wyart, Françoise (Institut Curie) ; García, Ángel (Hospital Universitari Vall d'Hebron) ; Alonso-Alconada, Lorena (Centro de Investigación Biomédica en Red de Cáncer) ; Abal Posada, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ; Díaz-Feijoo, Berta (Hospital Universitari Vall d'Hebron) ; Thomas, William (Department of Natural Sciences, Colby-Sawyer College, New London, New Hampshire, United States of America) ; Dufour, Sylvie (Present address: Université Paris Est, Faculté de Médecine, Créteil, France, INSERM, U955, Equipe 6, Créteil, France) ; Mancebo, Gemma (Hospital del Mar (Barcelona, Catalunya)) ; Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Endometrial cancer (EC) is the sixth deadliest cancer in women. The depth of myometrial invasion is one of the most important prognostic factors, being directly associated with tumor recurrence and mortality. [...]
2018 - 10.18632/oncotarget.24625
Oncotarget, Vol. 9 (march 2018) , p. 16648-16664  
5.
14 p, 5.6 MB Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples / Martinez-Garcia, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lesur, Antoine (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Devis Jauregui, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campos, Alexandre (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ; Cabrera Díaz, Silvia (Hospital Universitari Vall d'Hebron) ; van Oostrum, Jan (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Matias-Guiu, Xavier (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Gil-Moreno, Antonio 1965- (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Reventos, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás Ortega, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Domon, Bruno (Luxembourg Clinical Proteomics Center (LCP), Luxembourg Institute of Health (LIH), Strassen, Luxembourg) ; Universitat Autònoma de Barcelona
About 30% of endometrial cancer (EC) patients are diagnosed at an advanced stage of the disease, which is associated with a drastic decrease in the 5-year survival rate. The identification of biomarkers in uterine aspirate samples, which are collected by a minimally invasive procedure, would improve early diagnosis of EC. [...]
2016 - 10.18632/oncotarget.10632
Oncotarget, Vol. 7 (july 2016) , p. 53102-53115  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.